Jesse D Ortendahl

4PUBLICATIONS
42CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 31, 2026
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors.

Jesse D Ortendahl, Gebra Cuyun Carter, Eliza M Zantema

|Jun 17, 2025
Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non-Small Cell Lung Cancer.

Jesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar

|Jun 03, 2024
Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection.

Peter J Mazzone, Peter B Bach, Jacob Carey

|Mar 11, 2024
Value of next generation sequencing (NGS) testing in advanced cancer patients.

Jesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar

Pageof 1